# Appen vs Lunit Appen records 665,840 monthly visits with +0.2% month-over-month growth and Contact for Pricing pricing. Lunit records 29,181 monthly visits with -12.8% growth and Contact for Pricing pricing. | Metric | [Appen](https://openaitools.app/tool/appen-com) | [Lunit](https://openaitools.app/tool/lunit) | | :--- | :--- | :--- | | Website URL | https://appen.com | https://www.lunit.io/en | | Categories | AI Models, Large Language Models (LLMs), AI Developer Tools | AI Healthcare, AI Medical Diagnosis, AI Image Recognition | | Pricing Model | Contact for Pricing | Contact for Pricing | | Monthly Visits | 665,840 | 29,181 | | MoM Growth Rate | +0.2% | -12.8% | | Primary Market | United States | South Korea | | Direct Visits | 238,314 | 8,314 | | Review Score | 4.4 | 4.6 | | Saved Count | 2 | 1 | | Supported Platforms | Website | Website | ## Appen Appen is one of the oldest pure-play AI data companies, tracing its roots to 1996 when it began building human-labeled datasets for speech recognition and NLP. Over three decades it supported successive generations of model development — search relevance in the 2000s, machine translation, deep-learning vision annotation, Transformer-era semantics, GPT-3 scale corpora, RLHF for conversational AI, and now agentic and multimodal foundation models. Today Appen positions itself around six specialised capability areas: Frontier Alignment (chain-of-thought reasoning traces, SME RLHF, supervised fine-tuning demonstrations, adversarial red teaming), Agentic AI (golden trajectories, RL environment design, failure-mode taxonomies, SWE-driven evaluation), Multimodal and Speech AI (multilingual ASR and conversational corpora, expressive TTS annotation, VLM training data, video action labelling), Physical AI (LiDAR point-cloud annotation, multi-camera sensor fusion, robotics demonstration trajectories, world-model rollouts), Model Integrity (hallucination benchmarking, bias detection, regulatory audits and continuous monitoring), and Research Services (context engineering, calibrated LLM-as-a-judge, synthetic data and custom benchmarking). Delivery runs through Appen's AI Data Platform (ADAP), which blends automation with human oversight, and the company cites SOC 2 and ISO 27001 certification, 500+ global locales, and a client roster that includes major cloud, search, retail and aerospace organisations. Appen does not publish self-serve pricing; engagements start with a scoping conversation and are quoted per project, so cost depends on data volume, language coverage, modality and annotation complexity. **Pricing & Plans:** Enterprise/contact-for-pricing. Appen does not publish self-serve plans; projects are scoped and quoted individually. Appen also sells off-the-shelf (OTS) datasets and crowd/contractor workforce programs with separate terms. - **Frontier alignment data:** Chain-of-thought reasoning traces, SME-level RLHF, supervised fine-tuning demonstrations and adversarial red teaming for the most capable models. - **Agentic AI datasets:** Golden trajectories, RL environment design, failure-mode taxonomies and software-engineering-driven deep evaluation for autonomous agents. - **Multimodal and speech corpora:** Multilingual ASR and conversational speech data, expressive TTS annotation, vision-language model training data, video action labelling and voice-agent evaluation. - **Physical AI annotation:** LiDAR point-cloud labeling, multi-camera sensor fusion, robot demonstration trajectories, world-model rollouts and embodied interaction logs. - **Model integrity and evaluation:** Hallucination benchmarking, bias detection, regulatory audits and continuous monitoring, plus independent model evaluation. - **AI Data Platform (ADAP):** A production platform that combines automation with human oversight, with SOC 2 and ISO 27001 certification and 500+ locales covered. **Strengths:** Three decades of annotation methodology, tooling and workforce management experience; Very broad coverage: frontier alignment, agentic, speech, multimodal, physical AI and evaluation in one vendor; 500+ locales and multilingual expertise that most in-house teams cannot match; Enterprise-grade security posture (SOC 2, ISO 27001) and publicly listed governance **Limitations:** No transparent self-serve pricing; every engagement requires a sales/scoping cycle; Enterprise-oriented contracts can be heavy for small teams or indie developers; Quality depends on workforce management, so results vary by project and locale; Overlaps with many cheaper specialist annotation vendors, making vendor selection non-trivial [Profile (Markdown)](https://openaitools.app/tool/appen-com.md) ## Lunit Lunit is a medical AI company headquartered in Seoul, South Korea, spun out of deep-learning research and focused squarely on oncology. Rather than chasing general-purpose healthcare AI, it has built two connected product families: one that helps clinicians find cancer earlier in imaging, and one that extracts quantitative biology from tissue to guide treatment and drug development. Its technology is used across a large international footprint spanning more than 10,000 customer sites in over 70 countries, with hundreds of peer-reviewed publications and industry partnerships behind the deployments. On the screening side, the Lunit INSIGHT family analyzes mammograms and chest radiographs. Lunit INSIGHT MMG handles 2D mammography while Lunit INSIGHT DBT covers 3D breast tomosynthesis, both designed to flag suspicious regions so radiologists can prioritize the studies that need attention most. Lunit INSIGHT CXR does the same for chest X-rays. Around these detection engines Lunit has assembled program-level tooling: density assessment, risk assessment and risk pathways, live mammography reporting, quality management, analytics, and a patient hub, so a screening service can run AI as part of its routine rather than as an isolated experiment. On the precision oncology side, the Lunit SCOPE portfolio analyzes pathology images. Lunit SCOPE IO quantifies the tumor microenvironment and immune cell infiltration, which matters for immunotherapy strategy, while the Lunit SCOPE IHC Suite supports immunohistochemistry quantification across markers such as HER2 and PD-L1, alongside a genotype prediction tool. These products are aimed at biopharma partners, clinical trial teams, and companion diagnostic development, where reproducible quantitative readouts are the bottleneck. Because Lunit sells to hospitals, screening programs, and pharmaceutical companies, pricing is quoted directly rather than published, and regulatory status differs by market. **Pricing & Plans:** Contact for pricing. Lunit sells enterprise software and platform licenses to hospitals, screening programs, and biopharma partners, so commercial terms and deployment costs are quoted directly through its sales team. No public price list is offered. - **Lunit INSIGHT MMG and DBT:** Deep-learning analysis of 2D and 3D mammography that marks suspicious lesions to help radiologists detect breast cancer earlier and reduce missed findings. - **Lunit INSIGHT CXR:** Chest X-ray analysis that highlights potential abnormalities such as nodules and other findings, supporting faster triage in high-volume radiology workflows. - **Lunit SCOPE IO:** Tumor microenvironment analysis that quantifies tumor-infiltrating lymphocytes and immune phenotypes from pathology slides, informing immunotherapy research. - **Lunit SCOPE IHC Suite:** AI-assisted immunohistochemistry quantification covering HER2, PD-L1, and other markers, including uIHC and a gene-expression prediction tool for standardized scoring. - **Screening analytics and workflow tools:** Live mammography reporting, risk assessment, risk pathways, quality management, and patient-facing tools that embed AI into the wider screening program. **Strengths:** Clinically validated radiology AI with documented regulatory clearances and published evidence; Covers two ends of the cancer pathway — screening detection and precision oncology biomarkers — in one vendor relationship; Wide real-world adoption across many countries, which means integrations and workflow lessons already exist; Strong research output and biopharma partnerships support credibility for trial and CDx work [Profile (Markdown)](https://openaitools.app/tool/lunit.md) ## Frequently Asked Questions ### How do Appen and Lunit compare in monthly traffic? Appen has 665,840 monthly visits, while Lunit has 29,181. Traffic estimates describe audience size, not product quality. ### How do their growth rates compare? Appen has a month-over-month growth rate of +0.2%; Lunit has -12.8%. ### How does pricing compare? Appen: Contact for Pricing. Enterprise/contact-for-pricing. Appen does not publish self-serve plans; projects are scoped and quoted individually. Appen also sells off-the-shelf (OTS) datasets and crowd/contractor workforce programs with separate terms. Lunit: Contact for Pricing. Contact for pricing. Lunit sells enterprise software and platform licenses to hospitals, screening programs, and biopharma partners, so commercial terms and deployment costs are quoted directly through its sales team. No public price list is offered. ## Alternatives | # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | 1 | [Prolific](https://openaitools.app/tool/prolific-com) | 18,697,671 | -1.8% | Paid | Connects teams directly with verified human participants for preference tuning and studies, but lacks managed end-to-end labeling pipelines. | [.md](https://openaitools.app/tool/prolific-com.md) | | 2 | [Invisible Technologies](https://openaitools.app/tool/invisible-technologies-inc) | 1,364,520 | +64.4% | Contact for Pricing | Blends custom software with dedicated human expert teams to handle complex operations, but operates as a bespoke service. | [.md](https://openaitools.app/tool/invisible-technologies-inc.md) | | 3 | [Labelbox](https://openaitools.app/tool/labelbox) | 762,803 | -22.8% | Contact for Pricing | Combines robust data labeling tools with automated workflows, but focuses more on software tooling than managed human workforces. | [.md](https://openaitools.app/tool/labelbox.md) | | 4 | [Scale](https://openaitools.app/tool/scale) | 616,915 | +12.5% | Contact for Pricing | Provides enterprise-grade AI training data and model evaluation at massive scale, but often with higher enterprise pricing. | [.md](https://openaitools.app/tool/scale.md) | | 5 | [SuperAnnotate](https://openaitools.app/tool/super-annotate) | 386,034 | +37.4% | Free Trial, Contact for Pricing | Delivers advanced multimodal data curation and annotation infrastructure, but requires your own annotation workforce for labeling tasks. | [.md](https://openaitools.app/tool/super-annotate.md) | | 6 | [ScanSkinAI](https://openaitools.app/tool/scanskinai) | 265,770 | -10.9% | Freemium, Paid | Free AI skin and mole scanning with optional dermatologist review | [.md](https://openaitools.app/tool/scanskinai.md) | | 7 | [Overjet](https://openaitools.app/tool/overjet-ai) | 256,150 | +12.6% | Contact for Pricing | FDA-cleared dental AI for diagnostics, imaging, and insurance workflow | [.md](https://openaitools.app/tool/overjet-ai.md) | | 8 | [Arize AI](https://openaitools.app/tool/arize-com) | 249,028 | +3.2% | Paid, Contact for Pricing | Agent observability, evaluation, and continuous improvement for production AI | [.md](https://openaitools.app/tool/arize-com.md) | | 9 | [Encord](https://openaitools.app/tool/encord-com) | 244,204 | +9.4% | Contact for Pricing | The multimodal data layer for computer vision and physical AI teams | [.md](https://openaitools.app/tool/encord-com.md) | | 10 | [Pearl](https://openaitools.app/tool/hellopearl-com) | 221,155 | -7.6% | Contact for Pricing | FDA-cleared dental AI for sharper diagnosis and a smoother front office | [.md](https://openaitools.app/tool/hellopearl-com.md) | --- Source: https://openaitools.app/compare/appen-com-vs-lunit More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)